A spokesperson for Monsanto said in a statement that the company believes the “cross-examination regarding risks factors for [the plaintiffs’] injury was appropriate given the evidentiary record in this case. The spokesperson called the plaintiffs’ decision to seek a mistrial “unusual and telling.

Click Here To Read The Full Article